Equity
€52,269 ▲ 12.3%
P.H.A. has made a profit in every financial year since 2023.
P.H.A.
Lifetime
3 annual accounts with figures on one time axispeak €22,340 (2024)
€18,445▼ 17.4%
peak €22,297 (2024)
€5,743▼ 74.2%
peak €52,269 (2025)
€52,269▲ 12.3%
€7,778▲ 165%
Board1 name since 2023
1 director
Documentsfilings and deeds
19-08-202619 days late
2025micro format
Gross margin from €22,340 to €18,445Result from €22,297 to €5,743Equity from €46,527 to €52,269Debts from €2,934 to €7,778Cash from €33,542 to €44,211
Key points
from the 2025 annual accountsTurnover
≈ €190,000 estimated
The micro format states no turnover.
Liquidity
7.72 was 16.86 in 2024
Short-term debts rose from €2,934 to €7,778.
Filings
3 annual accounts 3 late
The 2024 accounts came latest: 28 days after the end of the period.
Starting capital
€2,000 100 shares
Position in the sector
87.0%
Higher solvency than 92% of companies in retail trade. Sector median 33.4% · 25,237 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,274 companies had the same profile as P.H.A. has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,274 companies, not a prediction for P.H.A.. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered-office move
Director in office: · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0804582039
Registered office moved from Brussels to Anderlecht
New registered office: avenue des Immortelles, 3 bte 33 à 1070 Anderlecht · Previous registered office: 9, Rue de L'Etendard, 1000 Bruxelles · General meeting of 10-10-2024 · Gazette deed
Incorporation
Founding capital of €2,000, 100 shares · Founder: · Appointment: (director) · published on 08-08-2023 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| P.H.A. Anderlecht | €60,047 | €18,445 | 87.0% | - |
| PHARMACIE PHARMISTE Brussels | €57,475 | €19,564 | 23.0% | - |
| BUMA PHARMA Antwerp | €57,247 | €22,296 | 67.3% | - |
| Bossiroy Pharma Uccle | €65,695 | €27,817 | 91.4% | - |
| KEPHAS PHARMA Pont-à-Celles | €57,577 | €13,925 | 58.2% | - |
| Katrien Smets Heist-op-den-Berg | €56,328 | €18,249 | 61.8% | - |
| ERAPHAR Haaltert | €50,132 | €16,957 | 78.1% | - |
These companies have the same main activity as P.H.A.: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €50,100 and €65,700, founded between 2022 and 2024.
Official details
Source: KBO- Status
- Active since 04-08-2023Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Establishment unit
- 2.348.776.2121070 Anderlecht, since 04-08-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 06-02-2026
Insights on P.H.A.
P.H.A. files the micro format. That format states no turnover. The gross margin fell from €21,302 in 2023 to €18,445 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about P.H.A.
- What is the company number of P.H.A.?
- The company number of P.H.A. is 0804.582.039. The VAT number is the same number with BE in front: BE 0804.582.039.
- Where is P.H.A. based?
- The registered office is at Sint-Janskruidlaan 13, 1070 Anderlecht.Company details
- What does P.H.A. do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of P.H.A.?
- P.H.A. is a private limited company (BV).
- When was P.H.A. founded?
- P.H.A. was founded on 04-08-2023.
- Is P.H.A. still active?
- Yes, P.H.A. is an active enterprise in the KBO register.
- What is the turnover of P.H.A.?
- The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €18,445 and 118 comparable companies (NACE 477). It probably lies between €71,000 and €410,000. It is a rough estimate.Financials
- Is P.H.A. profitable?
- In financial year 2025, P.H.A. made a profit of €5,743.
- Where can I find the annual accounts of P.H.A.?
- P.H.A. filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of P.H.A. due?
- P.H.A. must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.